| Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020 FP Havers, C Reed, T Lim, JM Montgomery, JD Klena, AJ Hall, AM Fry, ... JAMA internal medicine 180 (12), 1576-1586, 2020 | 733 | 2020 |
| Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021 SJ Olsen, AK Winn, AP Budd, MM Prill, J Steel, CM Midgley, K Kniss, ... Morbidity and Mortality Weekly Report 70 (29), 1013, 2021 | 284 | 2021 |
| Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 KL Bajema, RE Wiegand, K Cuffe, SV Patel, R Iachan, T Lim, A Lee, ... JAMA internal medicine 181 (4), 450-460, 2021 | 266 | 2021 |
| Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial C Hadigan, S Yawetz, A Thomas, F Havers, PE Sax, S Grinspoon Annals of internal medicine 140 (10), 786-794, 2004 | 265 | 2004 |
| Hospitalizations associated with COVID-19 among children and adolescents—COVID-NET, 14 states, March 1, 2020–August 14, 2021 MJ Delahoy, D Ujamaa, M Whitaker, A O'Halloran, O Anglin, E Burns, ... Morbidity and Mortality Weekly Report 70 (36), 1255, 2021 | 243 | 2021 |
| Outbreak of variant influenza A (H3N2) virus in the United States MA Jhung, S Epperson, M Biggerstaff, D Allen, A Balish, N Barnes, ... Clinical infectious diseases 57 (12), 1703-1712, 2013 | 180 | 2013 |
| Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons FP Havers, LA Hicks, JR Chung, M Gaglani, K Murthy, RK Zimmerman, ... JAMA network open 1 (2), e180243-e180243, 2018 | 153 | 2018 |
| Effectiveness of COVID-19 vaccines in preventing hospitalization among adults aged≥ 65 years—COVID-NET, 13 states, February–April 2021 HL Moline, M Whitaker, L Deng, JC Rhodes, J Milucky, H Pham, K Patel, ... Morbidity and Mortality Weekly Report 70 (32), 1088, 2021 | 152 | 2021 |
| Update: interim guidance for preconception counseling and prevention of sexual transmission of Zika virus for persons with possible Zika virus exposure—United States … EE Petersen, D Meaney-Delman, R Neblett-Fanfair, F Havers, T Oduyebo, ... Morbidity and Mortality Weekly Report 65 (39), 1077-1081, 2016 | 145 | 2016 |
| Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 states, July 2021–January 2022 KJ Marks, M Whitaker, O Anglin, J Milucky, K Patel, H Pham, SJ Chai, ... Morbidity and Mortality Weekly Report 71 (7), 271, 2022 | 144 | 2022 |
| Risk for in-hospital complications associated with COVID-19 and influenza—Veterans Health Administration, United States, October 1, 2018–May 31, 2020 J Cates, C Lucero-Obusan, RM Dahl, P Schirmer, S Garg, G Oda, AJ Hall, ... Morbidity and Mortality Weekly Report 69 (42), 1528, 2020 | 135 | 2020 |
| Racial and ethnic disparities in rates of COVID-19–associated hospitalization, intensive care unit admission, and in-hospital death in the United States from March 2020 to … AM Acosta, S Garg, H Pham, M Whitaker, O Anglin, A O’Halloran, ... JAMA network open 4 (10), e2130479-e2130479, 2021 | 130 | 2021 |
| Influenza and Tdap vaccination coverage among pregnant women—United States, April 2018 KE Kahn, CL Black, H Ding, WW Williams, PJ Lu, AP Fiebelkorn, F Havers, ... Morbidity and Mortality Weekly Report 67 (38), 1055, 2018 | 129 | 2018 |
| Risk factors for severe COVID-19 in children RC Woodruff, AP Campbell, CA Taylor, SJ Chai, B Kawasaki, J Meek, ... Pediatrics 149 (1), e2021053418, 2022 | 128 | 2022 |
| Use of national pneumonia surveillance to describe influenza A (H7N9) virus epidemiology, China, 2004–2013 N Xiang, F Havers, T Chen, Y Song, W Tu, L Li, Y Cao, B Liu, L Zhou, ... Emerging infectious diseases 19 (11), 1784, 2013 | 125 | 2013 |
| Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practices—United States, 2019 FP Havers, PL Moro, P Hunter, S Hariri, H Bernstein Morbidity and Mortality Weekly Report 69 (3), 77, 2020 | 121 | 2020 |
| Hospitalization of adolescents aged 12–17 years with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1, 2020–April 24, 2021 FP Havers, M Whitaker, JL Self, SJ Chai, PD Kirley, NB Alden, ... Morbidity and Mortality Weekly Report 70 (23), 851, 2021 | 114 | 2021 |
| Risk factors for influenza A (H7N9) disease—China, 2013 B Liu, F Havers, E Chen, Z Yuan, H Yuan, J Ou, M Shang, K Kang, K Liao, ... Clinical infectious diseases 59 (6), 787-794, 2014 | 114 | 2014 |
| Influenza and Tdap vaccination coverage among pregnant women—United States, April 2020 H Razzaghi, KE Kahn, CL Black, MC Lindley, TC Jatlaoui, AP Fiebelkorn, ... Morbidity and Mortality Weekly Report 69 (39), 1391, 2020 | 106 | 2020 |
| Influenza activity—United States, 2012–13 season and composition of the 2013–14 influenza vaccine L Brammer, K Kniss, S Epperson, L Blanton, D Mustaquim, C Steffens, ... Morbidity and Mortality Weekly Report 62 (23), 473, 2013 | 100 | 2013 |
